| 國立政治大學 |
2011-03 |
The effect of a self-efficacy enhancement strategy on hypnotic tapering in patients with primary insomnia
|
Tseng, C. H.; 楊建銘; Yang, C. M.; Lai, Y. S.; Hsu, S. C. |
| 中國醫藥大學 |
2011-01 |
Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.
|
(Song, H.); (Li, C-W.); (LaBaff, A. M.); (Lim, S-O.); 李龍緣(Long-Yuan Li); (Kan, S-F.); (Chen, Y.); (Zhang, K.); (Lang, J-Y.); (Xie, X.); (Wang, Y.); (Huo, L-F.); (Hsu, S-C.); (Chen, X-M.); (Zhao, Y-M.); 洪明奇(Mien-Chie Hung)* |
| 亞洲大學 |
2011 |
Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors.
|
李龍緣;Li, Long-Yuan;Wang, Y.;Huo, L-F.;Hsu, S-C.;Chen, X-M. |
| 臺大學術典藏 |
2011 |
I-m-Breath: The effect of multimedia biofeedback on learning abdominal breath
|
Yu M.-C.;Jin-Shing Chen;Chang K.-J.;Hsu S.-C.;Lee M.-S.;Hung Y.-P.; Yu M.-C.; JIN-SHING CHEN; Chang K.-J.; Hsu S.-C.; Lee M.-S.; Hung Y.-P. |
| 臺大學術典藏 |
2011 |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Ko B.-S.; Lee M.-C.; Kuo Y.-Y.; Chen C.-Y.; Hou H.-A.; Liu C.-Y.; Chou S.-C.; Chou W.-C.; HWEI-FANG TIEN; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F. |
| 臺大學術典藏 |
2011 |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Liu C.-Y.; SHENG-CHIEH CHOU; Chou W.-C.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo K.-T.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y. |
| 臺大學術典藏 |
2011 |
Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy
|
Chung T.-H.; Hsiao J.-K.; Huang D.-M.; Yang C.-S.; Wang S.-W.; Kuo M.Y.-P.; Chen Y.-C.; Hsu S.-C.; MING YAO |
| 臺大學術典藏 |
2011 |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Tang J.-L.; Ko B.-S.; Kuo Y.-Y.; Lee M.-C.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou S.-C.; Chou W.-C.; Huang C.-F.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lee F.-Y.; Kuo K.-T.; Kuo Y.-Y.; MING YAO; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2011 |
In vivo magnetic resonance imaging of cell tropsim, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model
|
Yang C.-S.; Chen Y.-C.; Lu C.-W.; Liu H.-M.; MING YAO; Hsu S.-C.; Hsiao J.-K.; Chien L.-Y.; Huang D.-M. |
| 臺大學術典藏 |
2011 |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Tseng M.-H.; Huang C.-F.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; Wu S.-J.; Tsay W.; Yao M.; Tang J.-L.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; Lei W.-C.; Chou W.-C.; HWEI-FANG TIEN |
